Av. Magalhaes de Castro, 4800
24° andar Edificio Continental Tower Bairro Cidade Jardim
Sao Paulo, SP 05676-120
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 7,089
|Mr. Breno Toledo Pires de Oliveira||Chief Exec. Officer||N/A||N/A||N/A|
|Mr. Adalmario Ghovatto Satheler do Couto||Investor Relations Officer & CFO||N/A||N/A||N/A|
|Mr. Carlos Roberto Scorsi||Chief Operating officer||N/A||N/A||1962|
|Juliana Aguinaga Damião Salem||Chief Legal & Compliance Officer||N/A||N/A||N/A|
|Mr. Nelson José de Mello||Chief Corp. Relations Officer||N/A||N/A||1959|
Hypera S.A. operates as a pharmaceutical company in Brazil. The company offers prescription medications under the Farmasa, Neo Química, and Luper brands; and over-the-counter medications comprising laxative, antacid, antispasmodic, topical antiseptic, topical, nasal decongestant, and other drugs under Gelol, Anapyon, Biotônico Fontoura, Epocler, Merthiolate, Tamarine, and Rinosoro brands. It also provides similars and generics under the Neo Química brand; dermocosmetics under the Lanidrant, Agecare, Dersab, Epidac, Epidrat, Episol, Hidramamy, Creme rejuvenecedor, Blancy, and Pielus brands; and food supplements and sweeteners. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. The company was founded in 2001 and is headquartered in São Paulo, Brazil.
Hypera S.A.’s ISS Governance QualityScore as of October 4, 2019 is 3. The pillar scores are Audit: 5; Board: 8; Shareholder Rights: 3; Compensation: 5.